Impact of laparoscopic ultrasound during PIPAC directed treatment of unresectable peritoneal metastasis [0.03%]
腹腔镜超声引导下PIPAC治疗不可切除的腹膜转移癌的影响
Magnus S Jørgensen,Alan P Ainsworth,Claus W Fristrup et al.
Magnus S Jørgensen et al.
Objectives: Laparoscopic ultrasound (LUS) combines both laparoscopy and ultrasound imaging of the peritoneum liver and retroperitoneum. LUS has not been described in treatments with pressurized intraperitoneal aerosol che...
Combined Nabpaclitaxel pressurized intraPeritoneal aerosol chemotherapy with systemic Nabpaclitaxel-Gemcitabine chemotherapy for pancreatic cancer peritoneal metastases: protocol of single-arm, open-label, phase II trial (Nab-PIPAC trial) [0.03%]
纳米白蛋白结合紫杉醇加吉西他滨联合纳米白蛋白结合紫杉醇气溶胶增压腹腔内化疗治疗胰腺癌腹膜转移的Ⅱ期单臂开放试验（ Nab-PIPAC试验）
Andrea Di Giorgio,Federica Ferracci,Cinzia Bagalà et al.
Andrea Di Giorgio et al.
Objectives: Current therapies show limited efficacy against peritoneal metastases (PM) from pancreatic cancer. Pressurized intra-peritoneal aerosol chemotherapy (PIPAC) has emerged as a novel intraperitoneal drug delivery...
Thromboelastogram changes are associated with postoperative complications after cytoreductive surgery [0.03%]
肿瘤细胞减灭术后血栓弹力图变化与术后并发症的关系
Noam Goder,Lilach Zac,Nadav Nevo et al.
Noam Goder et al.
Objectives: Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) is used to treat peritoneal surface malignancies. However, surgical morbidity is high, and prediction of severe postoperative c...
Vikas Pemmada,Athish Shetty,Prakashini Koteshwar et al.
Vikas Pemmada et al.
Objectives: Omental infarction (OI) is an uncommon cause of acute abdominal pain. A high index of clinical suspicion is required for diagnosis of OI as the incidence is less than 1 %, presenting with abdominal pain. We re...
Outcome of patients with peritoneal metastasis from ovarian cancer treated with Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) [0.03%]
用于治疗腹膜转移性卵巢癌患者的压入式腹腔内化疗（PIPAC）的疗效分析
Ingrid Terese Foslund,Sahra Aisha Vinholt von Magius,Alan Patrick Ainsworth et al.
Ingrid Terese Foslund et al.
Objectives: There are few data on Pressurized IntraPeritoneal Aerosol Chemotherapy with cisplatin and doxorubicin (PIPAC C/D) in women with primary unresectable or recurrent platinum-resistant peritoneal metastasis (PM) f...
Review on treatment of pleural metastasis and malignant pleural effusion with Pressurized IntraThoracic Aerosol Chemotherapy (PITAC) [0.03%]
加压胸腔内喷雾化疗(PITAC)治疗胸膜转移癌和恶性胸水的研究进展回顾
Pernille Schjødt Hansen,Martin Graversen,Sönke Detlefsen et al.
Pernille Schjødt Hansen et al.
Background: Malignant pleural effusion (MPE) is a common and debilitating condition seen in advanced cancer disease, and life-expectancy is short. Symptoms include pain and severe shortness of breath. Current first-line t...
RNA expression profiling of peritoneal metastasis from pancreatic cancer treated with Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) [0.03%]
用于治疗腹膜癌的加压腹腔内喷雾化疗(PIPSA)的RNA表达谱分析
Sönke Detlefsen,Mark Burton,Alan P Ainsworth et al.
Sönke Detlefsen et al.
Objectives: Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) is an experimental treatment option in peritoneal metastasis from pancreatic cancer (PM-PC). Aims were to examine mRNA profile of fibrosis due to respon...
Diagnostic and prognostic implications of bacteremia in patients with complicated pleural infection [0.03%]
并行感染患者菌血症的诊断及预后意义
Chang Ho Kim,Ji Eun Park,Jung Guen Cha et al.
Chang Ho Kim et al.
Objectives: The clinical significance of bacteremia in patients with complicated pleural infection is still uncertain. We aimed to examine the incidence and clinical significance of bacteremia in patients with complicated...
In vitro 3D microfluidic peritoneal metastatic colorectal cancer model for testing different oxaliplatin-based HIPEC regimens [0.03%]
体外三维微流控腹膜转移性结直肠癌模型用于测试不同的以奥沙利铂为基础的HIPEC方案
Aras Emre Canda,Tolga Sever,Gizem Calibasi Kocal et al.
Aras Emre Canda et al.
Objectives: Treatment of colorectal peritoneal metastases with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) is still evolving. Conducting a randomized trial is challenging due to the high he...
Implementation of ERAS guidelines in patients undergoing CRS and HIPEC: need for multicentre trial [0.03%]
ERAS指南在行CRS和HIPEC患者的实施：多中心临床试验的必要性
Christos Iavazzo,Ioannis D Gkegkes,John Spiliotis
Christos Iavazzo